<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Maize KM</submitter><funding>University of Minnesota College of Pharmacy</funding><funding>NIAID NIH HHS</funding><funding>American Foundation for Pharmaceutical Education Pre-Doctoral Fellowship</funding><funding>National Institutes of Health</funding><funding>University of Minnesota Doctoral Dissertation Fellowship</funding><funding>University of Minnesota Office of the Vice President for Research</funding><pagination>3836-41</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4688111</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>589(24 Pt B)</volume><pubmed_abstract>The Bacillus anthracis lethal factor (LF) is one component of a tripartite exotoxin partly responsible for persistent anthrax cytotoxicity after initial bacterial infection. Inhibitors of the zinc metalloproteinase have been investigated as potential therapeutic agents, but LF is a challenging target because inhibitors lack sufficient selectivity or possess poor pharmaceutical properties. These structural studies reveal an alternate conformation of the enzyme, induced upon binding of specific inhibitors, that opens a previously unobserved deep pocket termed S1'(∗) which might afford new opportunities to design selective inhibitors that target this subsite.</pubmed_abstract><journal>FEBS letters</journal><pubmed_title>Ligand-induced expansion of the S1' site in the anthrax toxin lethal factor.</pubmed_title><pmcid>PMC4688111</pmcid><funding_grant_id>R01 AI083234</funding_grant_id><pubmed_authors>Amin EA</pubmed_authors><pubmed_authors>Finzel BC</pubmed_authors><pubmed_authors>Kurbanov EK</pubmed_authors><pubmed_authors>Johnson RL</pubmed_authors><pubmed_authors>Maize KM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ligand-induced expansion of the S1' site in the anthrax toxin lethal factor.</name><description>The Bacillus anthracis lethal factor (LF) is one component of a tripartite exotoxin partly responsible for persistent anthrax cytotoxicity after initial bacterial infection. Inhibitors of the zinc metalloproteinase have been investigated as potential therapeutic agents, but LF is a challenging target because inhibitors lack sufficient selectivity or possess poor pharmaceutical properties. These structural studies reveal an alternate conformation of the enzyme, induced upon binding of specific inhibitors, that opens a previously unobserved deep pocket termed S1'(∗) which might afford new opportunities to design selective inhibitors that target this subsite.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Dec</publication><modification>2024-10-16T08:06:46.101Z</modification><creation>2019-03-27T02:05:38Z</creation></dates><accession>S-EPMC4688111</accession><cross_references><pubmed>26578066</pubmed><doi>10.1016/j.febslet.2015.11.005</doi></cross_references></HashMap>